BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

pSivida Corp 

400 Pleasant Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-926-5000 Fax: 617-926-5050


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Delivery





 Company News
pSivida Corp (PSDV) Reports Positive Regulatory Outcome For Iluvien®; Moves To National Phase For Marketing Authorizations In 10 More EU Countries 7/1/2014 8:55:03 AM
pSivida Corp (PSDV)'s Iluvien Gets Marketing Authorizations In 10 More EU Countries 6/30/2014 6:50:18 AM
pSivida Corp (PSDV) Announces ILUVIEN® Receives Marketing Authorization In Italy For Treatment Of Chronic Diabetic Macular Edema 6/23/2014 9:00:34 AM
pSivida Corp (PSDV) Reports Third Quarter 2014 Results 5/14/2014 7:02:30 AM
pSivida Corp (PSDV) Presents Preclinical Data Demonstrating Sustained Release Of Avastin Using Tethadur At Association for Research in Vision & Ophthalmology Annual Meeting 5/6/2014 7:06:27 AM
pSivida Corp (PSDV) Reports Australia/New Zealand Distribution Agreement For ILUVIEN® For DME 4/28/2014 10:48:29 AM
pSivida Corp (PSDV) Selected To Present At 2014 Opthalmology Innovation Summit 4/23/2014 7:24:57 AM
pSivida Corp (PSDV) CEO To Discuss Company’s Sustained Release Delivery System For Biologics At Two Upcoming Conferences 4/1/2014 9:06:26 AM
pSivida Corp (PSDV) Announces Resubmission Of New Drug Application For ILUVIEN® 3/27/2014 9:03:07 AM
pSivida Corp (PSDV) Announces $7.0 Million Investment By RA Capital 3/13/2014 7:56:16 AM
12345678910...